TRIDENT LIFELINE
|
The Current P/S Ratio of TRIDENT LIFELINE is 5.43.
| Share Price | ₹300.0 | Nov 04,2025 |
| Market Cap | ₹348.0 Cr | |
| Sales-TTM | ₹64.0 Cr | TTM-Consolidated Results |
| Price/Sales | 5.43x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of TRIDENT LIFELINE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹348.0 Cr] as on Nov 04,2025
(/) Sales [ ₹64.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.43x ]
Thus, for TRIDENT LIFELINE , the investors are currently willing to pay '5.43 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of TRIDENT LIFELINE !
The chart below summarizes the trend in P/S Ratio of TRIDENT LIFELINE over the last five years.
Historical PS (Price/Sales) ratio chart of TRIDENT LIFELINE
PS Ratio Performance Analysis for TRIDENT LIFELINE
- TRIDENT LIFELINE 's p/e ratio for fiscal years ending Mar2025 to Mar2022 averaged 3.35x.
- TRIDENT LIFELINE 's operated at median p/e ratio of 4.22x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, TRIDENT LIFELINE 's p/e ratio peaked in Mar2023 at 5.77x.
- TRIDENT LIFELINE 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does TRIDENT LIFELINE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| TRIDENT LIFELINE | 64.0 | 5.43 | 348.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.39 | 406,147.0 |
| DIVIS LABORATORIES LTD | 9,652.0 | 18.70 | 180,488.0 |
| CIPLA LTD | 28,349.6 | 4.28 | 121,452.0 |
| TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.23 | 121,057.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.92 | 100,220.0 |
| MANKIND PHARMA LTD | 12,956.2 | 7.55 | 97,796.9 |
| ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.15 | 97,891.5 |
| LUPIN LTD | 23,375.9 | 3.90 | 91,267.9 |
| AUROBINDO PHARMA LTD | 32,024.8 | 2.09 | 66,850.3 |
| ABBOTT INDIA LTD | 6,589.9 | 9.47 | 62,401.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TRIDENT LIFELINE 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.09x |
| Max industry PS | 18.70x |
| Median industry PS | 5.43x |
| Average industry PS | 6.92x |
You may also like the below Video Courses